SCHEMBL6135042

SCHEMBL6135042

CCOC(=O)c1ccc(N2CCC(OCCCC(C)C)CC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDFT1 P37268 1/20 0.44
HPGD P15428 2/20 0.43
HTT P42858 2/20 0.43
ALDH1A1 P00352 6/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPT P10636 2/20 0.43
HRH3 Q9Y5N1 1/20 0.43
HSP90AA1 P07900 2/20 0.41
CACNA1B Q00975 1/20 0.41
APBA1 Q02410 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TSHR P16473 1/20 0.41
BCHE P06276 1/20 0.41
SIRT2 Q8IXJ6 2/20 0.40
SIRT1 Q96EB6 2/20 0.40
MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6134525 0.89 HPGD (0.47) FDFT1HPGDHTTALDH1A1MEN1
SCHEMBL6134511 0.87 ALDH1A1 (0.47) FDFT1HPGDHTTALDH1A1MEN1
SCHEMBL7323856 0.86 ALDH1A1 (0.50) FDFT1HPGDHTTALDH1A1MEN1
SCHEMBL6132246 0.85 HTT (0.44) FDFT1HPGDHTTALDH1A1MEN1
SCHEMBL6132393 0.85 HTT (0.44) FDFT1HPGDHTTALDH1A1MEN1
SCHEMBL6135350 0.84 HDAC3 (0.47) ALDH1A1SMN1; SMN2MAPTTSHRBCHE
SCHEMBL6133982 0.83 HDAC3 (0.46) HPGDALDH1A1KMT2ASMN1; SMN2MAPT
SCHEMBL6134438 0.81 MEN1 (0.44) FDFT1HPGDHTTALDH1A1MEN1
SCHEMBL23839397 0.80 LIPG (0.47) FDFT1HPGDHTTALDH1A1MEN1
SCHEMBL21669102 0.80 LIPG (0.47) FDFT1HPGDHTTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050261177-A1 Compound ASTELLAS PHARMA INC. (JP) 2005-11-24 US disclosed
EP-1366066-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-12-03 EP disclosed
WO-2002072621-A2 CYCLOHEXAPEPTIDE HAVING ANTIMICROBIAL ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050261177-A1 Compound MANBA, MAN2B1, MAN2A1 FDFT1 363/4885HPGD 3433/4885HTT 3446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.